Experience

Ocular Therapeutix, Inc.

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Chief Business Officer

  • 2021 - Present

  Bedford, Massachusetts, United States As Chief Business Officer at Ocular Therapeutix, Chris is responsible for a number of corporate functions, including business development, alliance management, new product planning, and corporate strategy.

• Sr. Vice President, Head of Business and Corporate Development

  • 2019 - Sep 2021

  Bedford, MA



Silver Creek Pharmaceuticals, Inc.

• Chief Operating Officer

  • 2017 - 2019

  Silver Creek Pharmaceuticals is engineering a new class of biologics - Smart Growth Factors™ (SGFs) - that specifically target and prolong growth factor signaling in cells types/tissues of interest to promote repair. Our lead program, SGF-1, is a Smart Growth Factor™ which selectively accumulates in tissue where apoptosis is occurring. SGF-1 appears to reduce cardiac cell death following I/R injury. We are also evaluating SGFs in other organ system, including kidney (AKI), brain (TBI), and… Show more Silver Creek Pharmaceuticals is engineering a new class of biologics - Smart Growth Factors™ (SGFs) - that specifically target and prolong growth factor signaling in cells types/tissues of interest to promote repair. Our lead program, SGF-1, is a Smart Growth Factor™ which selectively accumulates in tissue where apoptosis is occurring. SGF-1 appears to reduce cardiac cell death following I/R injury. We are also evaluating SGFs in other organ system, including kidney (AKI), brain (TBI), and heart (CHF). Silver Creek’s proprietary technology platform supports the creation of customized growth factors targeting specific tissue types. Show less



Sofregen Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• President and Chief Operating Officer

  • 2016 - 2017

  Cambridge, Mass Sofregen develops and delivers innovative and transformative silk-based solutions for soft tissue defects, restoring confidence and improving the quality of life for medical and aesthetic patients around the world.



Entasis Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Chief Business Officer; Member, U.S. Board of Directors

  • 2015 - 2016

  Waltham, MA Entasis was recently established as a spin-out from AstraZeneca. The company’s mission is to discover and develop antibacterial medicines for hard to treat and drug resistant infectious diseases. Leading Entasis’ pipeline is AZD0914 in Phase II, the first of a novel class of topoisomerase inhibitors against Neisseria gonorrhoeae, which is increasingly resistant to existing treatments. The company also has multiple products in pre-clinical development. Entasis research targets… Show more Entasis was recently established as a spin-out from AstraZeneca. The company’s mission is to discover and develop antibacterial medicines for hard to treat and drug resistant infectious diseases. Leading Entasis’ pipeline is AZD0914 in Phase II, the first of a novel class of topoisomerase inhibitors against Neisseria gonorrhoeae, which is increasingly resistant to existing treatments. The company also has multiple products in pre-clinical development. Entasis research targets specific pathogens in diseases with high unmet medical need and that are scientifically challenging. As CBO at Entasis, my responsibilities will include business development, strategy and commercial planning. Show less



AMAG Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Chief Business Officer

  • 2007 - 2014

  Lexington, MA At AMAG Pharmaceuticals, I lead a broad range of strategic planning, business development and operating functions. Specific leadership responsibilities include: - Business Development: Establishing two partnerships to bring AMAG’s lead product, Feraheme, to market outside the United States. - Corporate Planning: Creating annual strategic plans to establish priorities and guide investment strategies. - Technical Operations and Quality: Leading manufacturing… Show more At AMAG Pharmaceuticals, I lead a broad range of strategic planning, business development and operating functions. Specific leadership responsibilities include: - Business Development: Establishing two partnerships to bring AMAG’s lead product, Feraheme, to market outside the United States. - Corporate Planning: Creating annual strategic plans to establish priorities and guide investment strategies. - Technical Operations and Quality: Leading manufacturing and quality functions at AMAG’s own Cambridge-based production facility, as well as activities relating to AMAG’s second source drug substance and drug product manufacturing network. - Portfolio Strategy: Leading portfolio planning activities, which create life cycle management plans and establish investment priorities for AMAG’s product portfolio. - Program Management: Leading program management, the function at AMAG that manages and leads critical, team-based activities in numerous functional areas, including product development, technical operations, and commercial planning. - Alliance Management: Leading AMAG’s strategic alliances, include our Feraheme partnerships with 3SBio and Takeda. Show less



Accenture

• Ireland
• Business Consulting and Services
• 700 & Above Employee

• Partner, Health and Life Sciences

  • 2005 - 2007

  Boston, MA Line partner responsible for annual sales/delivery of $30 MM in high-value management consulting services to the biopharmaceutical industry. Head of strategy for Accenture's Pharmaceutical and Medical Products group, a $400+ MM business in North America. Responsible for the recruiting, hiring, staffing and performance evaluations of 40+ consultants and partners.



Kearney

• United States
• Business Consulting and Services
• 700 & Above Employee

• Partner

  • Apr 1998 - Jun 2005

  Cambridge, MA Partner in the Pharmaceuticals and Health Care Practice



Arthur D. Little

• Belgium
• Business Consulting and Services
• 700 & Above Employee

• Senior Manager

  • 1994 - 1998

  Cambridge, MA Led various strategic planning engagements in the pharmaceutical industry, including commercial assessments, product launch planning, therapeutic category planning, market entry strategy and M&A/due diligence.



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Product Manager, U.S. Hospital Marketing Group

  • 1993 - 1994

  West Point, PA

• Manager, Strategic Planning, U.S. Human Health

  • 1992 - 1993

  West Point, PA

• Marketing Analyst, Business Research & Testing

  • 1991 - 1992

  West Point, PA



DuPont Pharmaceuticals

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Sales Representative

  • 1986 - 1989

• Sales Representative

  • 1986 - 1989